IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505,991 | +10.6% | 11,155 | 0.0% | 0.03% | +8.0% |
| Q2 2023 | $457,690 | +14.8% | 11,155 | -0.0% | 0.02% | +13.6% |
| Q1 2023 | $398,751 | -5.8% | 11,157 | -0.5% | 0.02% | -12.0% |
| Q4 2022 | $423,477 | -15.0% | 11,212 | -0.4% | 0.02% | -24.2% |
| Q3 2022 | $498,000 | +19.7% | 11,255 | +0.2% | 0.03% | +26.9% |
| Q2 2022 | $416,000 | +0.2% | 11,235 | +0.2% | 0.03% | -3.7% |
| Q1 2022 | $415,000 | +21.0% | 11,212 | -0.5% | 0.03% | +22.7% |
| Q4 2021 | $343,000 | -8.0% | 11,274 | +1.3% | 0.02% | -15.4% |
| Q3 2021 | $373,000 | -16.0% | 11,134 | +0.1% | 0.03% | -25.7% |
| Q2 2021 | $444,000 | -11.0% | 11,120 | +0.2% | 0.04% | -68.2% |
| Q1 2021 | $499,000 | -20.5% | 11,100 | 0.0% | 0.11% | -29.0% |
| Q4 2020 | $628,000 | +18.9% | 11,100 | -0.2% | 0.16% | -3.1% |
| Q3 2020 | $528,000 | – | 11,120 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |